Leon Wang, executive vice-president of AstraZeneca and president of AstraZeneca China, told China Daily in a previous interview that AstraZeneca hopes to contribute to the high-quality development of the domestic economic cycle in China, one of the company's crucial strategic markets worldwide.

Going forward, AstraZeneca will further deepen its market presence in the country through its regional headquarters strategy while supporting local economic development and driving dual-circulation development, he said.

Zhang Fei, associate director of the Institute of Foreign Investment, which is part of the Chinese Academy of International Trade and Economic Cooperation, said that she expects the Chinese government to make more moves to increase FDI inflows and improve FDI structure in manufacturing.

Sectors like automobile manufacturing, medical equipment, biomedicine, aerospace, chemicals and energy have great potential to boost FDI in China, she said.

liuzhihua@chinadaily.com.cn